SG Americas Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60K Buy
+20,000
New +$3.33M ﹤0.01% 3190
2026
Q1
Sell
-170,000
Closed -$290K 3592
2025
Q4
$290K Buy
170,000
+136,700
+411% +$42.7M ﹤0.01% 2768
2025
Q3
$61K Buy
+33,300
New +$10.4M ﹤0.01% 3170
2024
Q1
Sell
-11,000
Closed -$496K 3339
2023
Q4
$496K Sell
11,000
-8,900
-45% -$1.53M ﹤0.01% 1493
2023
Q3
$6K Buy
+19,900
New +$4.46M ﹤0.01% 3070

Other funds holding PODD

SG Americas Securities's PODD Position: Q2 2026 in Review

SG Americas Securities reduced its Insulet (PODD) stake by 68% in Q2 2026, selling an estimated $36.2M and leaving 101,745 shares worth $15.5M. The position accounts for 0.01% of the portfolio, ranked #687.

SG Americas Securities first reported a position in PODD in Q2 2013 and has held it in 46 quarters since. The position peaked at $66.9M in Q1 2026. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • SG Americas Securities held 101,745 shares of Insulet worth $15.5M as of Q2 2026.
  • SG Americas Securities sold 217,103 Insulet shares in Q2 2026, an estimated $36.2M.
  • Insulet made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #687 holding.
  • SG Americas Securities first reported a position in Insulet in Q2 2013 and has held it in 46 quarters since.
  • SG Americas Securities's Insulet position peaked at $66.9M in Q1 2026.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.